Courier Capital LLC Cara Therapeutics, Inc. Transaction History

Courier Capital LLC

  • $1.44 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 04, 2019
SELL
$18.28 - $26.91 $182,800 - $269,100
-10,000 Closed
0 $0
Q4 2018

Feb 08, 2019
SELL
$12.45 - $23.47 $24,900 - $46,940
-2,000 Reduced 16.67%
10,000 $130,000
Q4 2017

Jan 25, 2018
BUY
$11.86 - $14.08 $142,320 - $168,960
12,000
12,000 $147,000

Others Institutions Holding CARA

# of Institutions
74
Shares Held
12.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $15.6M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Courier Capital LLC Portfolio

Follow Courier Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Courier Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Courier Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email